Abstract

Objectives: To assess the relationships of Microalbuminuria with HbAlc and Fasting plasma glucose in type 2 diabetes mellitus (T2DM) patients at the National Hospital of Endocrinology from 2022 to 2023. Subjects and Methods: A cross-sectional descriptive study was conducted on 400 type
2 diabetes mellitus patients, divided into two groups: those with microalbuminuria and those without microalbuminuria. Results: Among 400 type 2 diabetes mellitus patients, 165 were positive for microalbuminuria, accounting for 41.25%.
There was a significant correlation between HbAlc and microalbuminuria (r = 0,57, p<0,05). However, there was no significant correlation between fasting plasma glucose and microalbuminuria (I = 0,032; P<0,05). Fasting plasma glucose ≥ 7 mmol/L and HbA1C ≥ 7% increased the risk of microalbuminuria in type 2 diabetes mellitus. Conclusions: The was a strong relationship between glycemic control and microalbuminuria in type 2 diabetes mellitus patients.